Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.


  1. Advanced Patent Search
Publication numberUS1270271 A
Publication typeGrant
Publication dateJun 25, 1918
Filing dateMar 25, 1918
Priority dateMar 25, 1918
Publication numberUS 1270271 A, US 1270271A, US-A-1270271, US1270271 A, US1270271A
InventorsMarion Dorset, Robert R Henley
Original AssigneeMarion Dorset, Robert R Henley
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Process for the separation of blood-serum.
US 1270271 A
Abstract  available in
Previous page
Next page
Claims  available in
Description  (OCR text may contain errors)

- No Drawing.


mam nonsn'r, or WASHINGTON, nrs'mrc'r or commnm, m nonnrvr n. HENLEY,

or TAKOMA PARK, mnzaynmn.



To all whom it may concern:

Be it known'that we, MARION Donsn'r, a citizen of the United States, residing in Washington, District of Columbia, and whose P. 0. address is Department of Agriculture, Washington, D. C., and Roman HENLEY, a citizen of the United States, residing in Takoma Park, Maryland, and whose P. 0. address is Department of Agriculture, Washington, D. C., have invented a new and useful process for the separation of blood-serum from blood-cells, and in particular for the separation of hog-choleraserum antitoxin from the cells contained in defibrinated-blood antitoxin.

' This application is made under the act of March 3, 1883, chapter 143 (22 Stat, 625), and the invention herein described and claimed may be used by the Government of theUnited States or any of its ofiicers or employees in the prosecution of work for the Government, or any person in the United SItates without payment to us of any roya ty. 4

Antitoxins, including hog cholera antitoxin, are obtained from the immunized animals by bleeding and the blood so drawn is usually either defibrinated by whipping or mixed with suitable anticoagulants to prevent the formationof fibrin. In either form there are present a solid,'or semi-solid portion consisting principally of red blood cells,

and a fluid portion which contains the antibodies. The fluid portion of the defibrinated blood is known as serum, while the fluid obtained from blood in which clotting has been prevented by the addition of anticoagulants is known as plasma.

The serum and plasma are separated .from the cells by centrifugation. The amount of clear fluid that can be separated from the cells by either method varies considerably, depending upon the source of the blood. Hogs blood yields ordinarily not more than and horse blood not more than 60%.

We have discovered that if neutral chemical salts in certain portions be added to blood, either defibrinated, citrated or oxa- Speoiflcation of Letters Patent.

Application filed March 25, 1918.

Patented June 25, 1918.

Serial No. 224,675.

dium chlorid, is added either as crystals or in solution in water, and is added in an amount suflicient to give the maximum yield of fluid without hemolyzing the cells. We have preferred to add an amount of salt sufiicient to give a total concentration of from 2% to 3% salt in the final mixture. Following the addition of the salt, the fluid portion of the blood is separated from the solid portion by a suitable mechanical process. We ordinarily employ centrifugation for this purpose, but mere sedimentation may be employed.

aving described our process, we claim:

1. The process of adding to the defibrinated blood a neutral chemical salt to cause the contraction of the cells whereby their volume is diminished and the volume of clear fluid is increased Without precipitation of the serum globulins or other soluble constituents.

2. The process of adding to blood, in which the formation of fibrin has been prevented, a neutral chemical salt to cause the contraction of the cells whereby their volume is diminished and the volume of clear fluid is increased without precipitation of the fibrinogen, serum globulins or other soluble constituents.

In testimony whereof, we afiix our signatures in the presence of two subscribing witnesses.


Witnesses C. N. MoBRYnE, FRANK W. TILLEY. I

Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US4322275 *Oct 16, 1980Mar 30, 1982Ionics IncorporatedFractionation of protein mixtures
US4351710 *Dec 15, 1980Sep 28, 1982Ionics, IncorporatedFractionation of protein mixtures
U.S. Classification424/162.1, 424/531, 424/680, 424/529, 424/130.1
Cooperative ClassificationC07K16/1081